News

Duke scientists may have discovered a game-changing painkiller. SBI-810 is a new non-opioid drug that offers potent pain ...
While opioids interact with numerous cellular pathways, the experimental drug is more selective. SBI-810 targets a receptor in the brain and spinal cord, activating a single pain-relief signal while ...
Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...
Scientists at Duke University have developed a new experimental drug that may offer strong pain relief without the risks ...
A groundbreaking study reveals the efficacy of SBI-810, a non-opioid pain reliever, in mice. This novel compound targets ...
New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa ...
The Boston Public Health Commission released data last week that showed a 38% decrease in overdose deaths compared to 2023.
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the publication of its study investigating Caldolor® (intravenous ibuprofen) in older patients. The ...